Molecular basis of the long-QT syndrome associated with deafness.

Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci U S A (2005) 4.14

Long QT syndrome: from channels to cardiac arrhythmias. J Clin Invest (2005) 2.71

Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nat Neurosci (2010) 2.00

A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Proc Natl Acad Sci U S A (2004) 1.98

Voltage-dependent inactivation of the human K+ channel KvLQT1 is eliminated by association with minimal K+ channel (minK) subunits. J Physiol (1998) 1.88

The role of S4 charges in voltage-dependent and voltage-independent KCNQ1 potassium channel complexes. J Gen Physiol (2007) 1.52

Genome-wide association studies in cardiac electrophysiology: recent discoveries and implications for clinical practice. Heart Rhythm (2010) 1.45

Kcne2 deletion uncovers its crucial role in thyroid hormone biosynthesis. Nat Med (2009) 1.36

Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue. Proc Natl Acad Sci U S A (2014) 1.36

Identification of a protein-protein interaction between KCNE1 and the activation gate machinery of KCNQ1. J Gen Physiol (2010) 1.06

HERG1 channelopathies. Pflugers Arch (2009) 1.06

Arrhythmias in the congenital long QT syndrome: how often is torsade de pointes pause dependent? Heart (2000) 1.03

Genotype- and phenotype-guided management of congenital long QT syndrome. Curr Probl Cardiol (2013) 1.01

Regulation of the Kv2.1 potassium channel by MinK and MiRP1. J Membr Biol (2009) 1.00

O-glycosylation of the cardiac I(Ks) complex. J Physiol (2011) 0.99

IKs channels open slowly because KCNE1 accessory subunits slow the movement of S4 voltage sensors in KCNQ1 pore-forming subunits. Proc Natl Acad Sci U S A (2013) 0.99

Nav1.5/R1193Q polymorphism is associated with both long QT and Brugada syndromes. Can J Cardiol (2006) 0.99

Serial perturbation of MinK in IKs implies an alpha-helical transmembrane span traversing the channel corpus. Biophys J (2007) 0.98

Unraveling monogenic channelopathies and their implications for complex polygenic disease. Am J Hum Genet (2003) 0.96

Long QT syndrome in South Africa: the results of comprehensive genetic screening. Cardiovasc J Afr (2013) 0.94

Impact of ancillary subunits on ventricular repolarization. J Electrocardiol (2007) 0.89

Voltage-dependent C-type inactivation in a constitutively open K+ channel. Biophys J (2008) 0.89

KCNE1 and KCNE3: The yin and yang of voltage-gated K(+) channel regulation. Gene (2015) 0.89

KCNE genetics and pharmacogenomics in cardiac arrhythmias: much ado about nothing? Expert Rev Clin Pharmacol (2013) 0.85

Cardiac ion channelopathies and the sudden infant death syndrome. ISRN Cardiol (2012) 0.84

Channelopathies: ion channel defects linked to heritable clinical disorders. J Med Genet (2000) 0.82

The long QT syndrome. Indian Pacing Electrophysiol J (2002) 0.82

KCNQ potassium channels in sensory system and neural circuits. Acta Pharmacol Sin (2015) 0.80

Identification of polymorphisms and balancing selection in the male infertility candidate gene, ornithine decarboxylase antizyme 3. BMC Med Genet (2006) 0.80

Genotype-phenotype analysis of three Chinese families with Jervell and Lange-Nielsen syndrome. J Cardiovasc Dis Res (2012) 0.75

Empirical correlation of triggered activity and spatial and temporal re-entrant substrates with arrhythmogenicity in a murine model for Jervell and Lange-Nielsen syndrome. Pflugers Arch (2009) 0.75

Ion channels--molecular divining rods hit their clinical mark. N Engl J Med (1997) 0.75

Measure of the QT-RR dynamic coupling in patients with the long QT syndrome. Ann Noninvasive Electrocardiol (2012) 0.75

Clinical and molecular findings in a Moroccan family with Jervell and Lange-Nielsen syndrome: a case report. J Med Case Rep (2017) 0.75

Human iPS cell models of Jervell and Lange-Nielsen syndrome. Rare Dis (2015) 0.75

Molecular basis of the long-QT syndrome. N Engl J Med (1997) 0.75

Molecular biology of human arrhythmias: implications for the clinical electrophysiologist. J Interv Card Electrophysiol (1998) 0.75

Impact of recent molecular studies on evaluation of ventricular arrhythmias. J Interv Card Electrophysiol (2000) 0.75

A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell (1995) 11.62

A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell (1995) 10.18

Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature (1996) 9.77

SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell (1995) 7.73

Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation (2000) 7.50

Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47

Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet (1996) 7.35

Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature (1998) 7.26

MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell (1999) 5.49

Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nat Genet (1993) 5.09

Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation (2000) 5.09

Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation (1995) 4.48

Diagnostic criteria for the long QT syndrome. An update. Circulation (1993) 4.48

The long QT syndrome. Prospective longitudinal study of 328 families. Circulation (1991) 3.99

The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med (1992) 3.92

Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet (1997) 3.90

Fast inactivation causes rectification of the IKr channel. J Gen Physiol (1996) 3.88

ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation (1995) 3.79

Elastin is an essential determinant of arterial morphogenesis. Nature (1998) 3.56

Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med (1998) 3.41

Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science (1991) 3.38

Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science (1998) 3.22

The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis. Cell (1993) 2.99

Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation (2000) 2.95

Dedifferentiation of mammalian myotubes induced by msx1. Cell (2000) 2.72

Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. Circulation (1996) 2.70

Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci U S A (1996) 2.63

Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation (1998) 2.53

LIM-kinase1 hemizygosity implicated in impaired visuospatial constructive cognition. Cell (1996) 2.44

Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics (1996) 2.44

Novel arterial pathology in mice and humans hemizygous for elastin. J Clin Invest (1998) 2.41

Roles for Fgf signaling during zebrafish fin regeneration. Dev Biol (2000) 2.36

The common SCN5A mutation R1193Q causes LQTS-type electrophysiological alterations of the cardiac sodium channel. J Med Genet (2004) 2.33

Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet (1995) 2.30

Multiple mechanisms of Na+ channel--linked long-QT syndrome. Circ Res (1996) 2.29

Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest (1996) 2.21

Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides. Circ Res (1996) 2.05

Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol (1996) 1.94

Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1. Genomics (1998) 1.93

Long QT syndrome associated with syndactyly identified in females. Am J Cardiol (1995) 1.93

Coronary spasm producing coronary thrombosis and myocardial infarction. N Engl J Med (1983) 1.91

Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. Circulation (1996) 1.86

Long QT syndrome-associated mutations in the Per-Arnt-Sim (PAS) domain of HERG potassium channels accelerate channel deactivation. J Biol Chem (1999) 1.82

Impaired distal airway development in mice lacking elastin. Am J Respir Cell Mol Biol (2000) 1.82

Elastin point mutations cause an obstructive vascular disease, supravalvular aortic stenosis. Hum Mol Genet (1997) 1.77

Processing of the platelet-derived growth factor receptor. Biosynthetic and degradation studies using anti-receptor antibodies. J Biol Chem (1987) 1.76

Q-T interval syndromes. Prog Cardiovasc Dis (1974) 1.69

Deletions of the elastin gene at 7q11.23 occur in approximately 90% of patients with Williams syndrome. Am J Hum Genet (1995) 1.68

Hypothesis for the molecular physiology of the Romano-Ward long QT syndrome. J Am Coll Cardiol (1992) 1.55

Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet (1994) 1.55

Supravalvular aortic stenosis associated with a deletion disrupting the elastin gene. J Clin Invest (1994) 1.54

New mutations in the KVLQT1 potassium channel that cause long-QT syndrome. Circulation (1998) 1.53

Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest (1996) 1.52

Induction of lef1 during zebrafish fin regeneration. Dev Dyn (2000) 1.48

A novel human gene, WSTF, is deleted in Williams syndrome. Genomics (1998) 1.47

Assessment of polymorphism in zebrafish mapping strains. Genome Res (1999) 1.37

Mammalian myotube dedifferentiation induced by newt regeneration extract. Proc Natl Acad Sci U S A (2001) 1.37

Single HERG delayed rectifier K+ channels expressed in Xenopus oocytes. Am J Physiol (1997) 1.37

Long QT syndrome-associated mutations in the S4-S5 linker of KvLQT1 potassium channels modify gating and interaction with minK subunits. J Biol Chem (1999) 1.33

Platelet-derived growth factor receptors expressed by cDNA transfection couple to a diverse group of cellular responses associated with cell proliferation. J Biol Chem (1988) 1.31

Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol (1999) 1.25

Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin Chem (1994) 1.24

Functional effects of mutations in KvLQT1 that cause long QT syndrome. J Cardiovasc Electrophysiol (1999) 1.23

A novel human gene FKBP6 is deleted in Williams syndrome. Genomics (1998) 1.21

KCNQ1 mutations in patients with a family history of lethal cardiac arrhythmias and sudden death. Clin Genet (2003) 1.16

Effects of exercise on heart rate, QT, QTc and QT/QS2 in the Romano-Ward inherited long QT syndrome. Am J Cardiol (1991) 1.16

Consistent linkage of the long-QT syndrome to the Harvey ras-1 locus on chromosome 11. Am J Hum Genet (1991) 1.15

ETL, a novel seven-transmembrane receptor that is developmentally regulated in the heart. ETL is a member of the secretin family and belongs to the epidermal growth factor-seven-transmembrane subfamily. J Biol Chem (2000) 1.10

Relation between outer and luminal diameter in cannulated arteries. Am J Physiol (1999) 1.08

Complete physical map of the common deletion region in Williams syndrome and identification and characterization of three novel genes. Hum Genet (1998) 1.06

Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease. Arterioscler Thromb Vasc Biol (1997) 1.05

Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome. J Am Coll Cardiol (1997) 1.01

Role of DNA testing for diagnosis, management, and genetic screening in long QT syndrome, hypertrophic cardiomyopathy, and Marfan syndrome. Heart (2001) 0.99

Clinically practical lead systems for improved electrocardiography: comparison with precordial grids and conventional lead systems. Circulation (1979) 0.92

Platelet derived growth factor (PDGF) autocrine components in human tumor cell lines. J Neurooncol (1990) 0.92

Clinical implications for affected parents and siblings of probands with long-QT syndrome. Circulation (2001) 0.92

Clinical and genetic variables associated with acute arousal and nonarousal-related cardiac events among subjects with long QT syndrome. Am J Cardiol (2000) 0.92

Long-QT syndrome-associated missense mutations in the pore helix of the HERG potassium channel. Circulation (2001) 0.90

The financial impact of Medicare diagnosis-related groups. Effect upon hospitals receiving cardiac patients referred for tertiary care. Chest (1987) 0.87